-
Alexander JP Jr, Baden L, Pallansch MA, Anderson LJ, 1994: Enterovirus 71 infections and neurologic disease—United States, 1977–1991[J]. J Infect Dis, 169, 905-908. doi: 10.1093/infdis/169.4.905
-
Ansardi DC, Porter DC, Morrow CD, 1992: Myristylation of poliovirus capsid precursor P1 is required for assembly of subviral particles[J]. J Virol, 66, 4556-4563. doi: 10.1128/JVI.66.7.4556-4563.1992
-
Arita M, Nagata N, Sata T, Miyamura T, Shimizu H, 2006: Quantitative analysis of poliomyelitis-like paralysis in mice induced by a poliovirus replicon[J]. J Gen Virol, 87, 3317-3327. doi: 10.1099/vir.0.82172-0
-
Boutin JA, 1997: Myristoylation[J]. Cell Signal, 9, 15-35. doi: 10.1016/S0898-6568(96)00100-3
-
Braam B, Verhaar MC, 2007: Understanding eNOS for pharmacological modulation of endothelial function: a translational view[J]. Curr Pharm Des, 13, 1727-1740. doi: 10.2174/138161207780831275
-
Bryant M, Ratner L, 1990: Myristoylation-dependent replication and assembly of human immunodeficiency virus 1[J]. Proc Natl Acad Sci USA, 87, 523-527. doi: 10.1073/pnas.87.2.523
-
Cao J, Liu H, Qu M, Hou A, Zhou Y, Sun B, Cai L, Gao F, Su W, Jiang C, 2019: Determination of the cleavage site of enterovirus 71 VP0 and the effect of this cleavage on viral infectivity and assembly[J]. Microb Pathog, 134, 103568-. doi: 10.1016/j.micpath.2019.103568
-
Chapman MS, Rossmann MG, 1993: Comparison of surface properties of picornaviruses: strategies for hiding the receptor site from immune surveillance[J]. Virology, 195, 745-756. doi: 10.1006/viro.1993.1425
-
Chow M, Moscufo N, 1995: Myristoyl modification of viral proteins: assays to assess functional roles[J]. Methods Enzymol, 250, 495-509. doi: 10.1016/0076-6879(95)50093-6
-
Chow M, Newman JF, Filman D, Hogle JM, Rowlands DJ, Brown F, 1987: Myristylation of picornavirus capsid protein VP4 and its structural significance[J]. Nature, 327, 482-486. doi: 10.1038/327482a0
-
Chumakov M, Voroshilova M, Shindarov L, Lavrova I, Gracheva L, Koroleva G, Vasilenko S, Brodvarova I, Nikolova M, Gyurova S, Gacheva M, 1979: Enterovirus 71 isolated from cases of epidemic poliomyelitis-like disease in Bulgaria[J]. Arch Virol, 60, 329-340. doi: 10.1007/BF01317504
-
Colomer-Lluch M, Serra-Moreno R, 2017: BCA2/Rabring7 Interferes with HIV-1 proviral transcription by enhancing the SUMOylation of IκBα[J]. J Virol, 91, e02098-16.
-
Corbic Ramljak I, Stanger J, Real-Hohn A, Dreier D, Wimmer L, Redlberger-Fritz M, Fischl W, Klingel K, Mihovilovic MD, Blaas D, Kowalski H, 2018: Cellular N-myristoyltransferases play a crucial picornavirus genus-specific role in viral assembly, virion maturation, and infectivity[J]. PLoS Pathog, 14, e1007203-. doi: 10.1371/journal.ppat.1007203
-
Courtneidge SA, Bishop JM, 1982: Transit of pp60v-src to the plasma membrane[J]. Proc Natl Acad Sci USA, 79, 7117-7121. doi: 10.1073/pnas.79.23.7117
-
Davis MP, Bottley G, Beales LP, Killington RA, Rowlands DJ, Tuthill TJ, 2008: Recombinant VP4 of human rhinovirus induces permeability in model membranes[J]. J Virol, 82, 4169-4174. doi: 10.1128/JVI.01070-07
-
Eash S, Querbes W, Atwood WJ, 2004: Infection of vero cells by BK virus is dependent on caveolae[J]. J Virol, 78, 11583-11590. doi: 10.1128/JVI.78.21.11583-11590.2004
-
Farazi TA, Waksman G, Gordon JI, 2001: The biology and enzymology of protein N-myristoylation[J]. J Biol Chem, 276, 39501-39504. doi: 10.1074/jbc.R100042200
-
Filman DJ, Syed R, Chow M, Macadam AJ, Minor PD, Hogle JM, 1989: Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus[J]. EMBO J, 8, 1567-1579. doi: 10.1002/j.1460-2075.1989.tb03541.x
-
Fuchs R, Blaas D, 2010: Uncoating of human rhinoviruses[J]. Rev Med Virol, 20, 281-297. doi: 10.1002/rmv.654
-
Geyer M, Peterlin BM, 2001: Domain assembly, surface accessibility and sequence conservation in full length HIV-1 Nef[J]. FEBS Lett, 496, 91-95. doi: 10.1016/S0014-5793(01)02394-8
-
Giese SI, Woerz I, Homann S, Tibroni N, Geyer M, Fackler OT, 2006: Specific and distinct determinants mediate membrane binding and lipid raft incorporation of HIV-1(SF2)[J]. Nef Virol, 355, 175-191. doi: 10.1016/j.virol.2006.07.003
-
Goodwin S, Tuthill TJ, Arias A, Killington RA, Rowlands DJ, 2009: Foot-and-mouth disease virus assembly: processing of recombinant capsid precursor by exogenous protease induces self-assembly of pentamers in vitro in a myristoylation-dependent manner[J]. J Virol, 83, 11275-11282. doi: 10.1128/JVI.01263-09
-
Gordon JI, Duronio RJ, Rudnick DA, Adams SP, Gokel GW, 1991: Protein N-myristoylation[J]. J Biol Chem, 266, 8647-8650.
-
Heuckeroth RO, Gordon JI, 1989: Altered membrane association of p60v-src and a murine 63-kDa N-myristoyl protein after incorporation of an oxygen-substituted analog of myristic acid[J]. Proc Natl Acad Sci USA, 86, 5262-5266. doi: 10.1073/pnas.86.14.5262
-
Hill BT, Skowronski J, 2005: Human N-myristoyltransferases form stable complexes with lentiviral nef and other viral and cellular substrate proteins[J]. J Virol, 79, 1133-1141. doi: 10.1128/JVI.79.2.1133-1141.2005
-
Horodniceanu F, Panon G, Le Fur R, Barme M, 1979: Purification of poliovirus obtained from human diploid cells by means of DEAE-Sepharose[J]. Dev Biol Stand, 42, 75-80.
-
Jiang P, Liu Y, Ma HC, Paul AV, Wimmer E, 2014: Picornavirus morphogenesis[J]. Microbiol Mol Biol Rev, 78, 418-437. doi: 10.1128/MMBR.00012-14
-
Jin J, Xu L, Guo SJ, Sun SY, Zhang S, Zhu CL, Kong W, Jiang CL, 2012: Safe and objective assay of enterovirus 71 neutralizing antibodies via pseudovirus[J]. Chem Res Chin U, 28, 91-95.
-
Jin J, Ma H, Xu L, An D, Sun S, Huang X, Kong W, Jiang C, 2013: Development of a Coxsackievirus A16 neutralization assay based on pseudoviruses for measurement of neutralizing antibody titer in human serum[J]. J Virol Methods, 187, 362-367. doi: 10.1016/j.jviromet.2012.11.014
-
Johnson DR, Cox AD, Solski PA, Devadas B, Adams SP, Leimgruber RM, Heuckeroth RO, Buss JE, Gordon JI, 1990: Functional analysis of protein N-myristoylation: metabolic labeling studies using three oxygen-substituted analogs of myristic acid and cultured mammalian cells provide evidence for protein-sequence-specific incorporation and analog-specific redistribution[J]. Proc Natl Acad Sci USA, 87, 8511-8515. doi: 10.1073/pnas.87.21.8511
-
Johnson DR, Bhatnagar RS, Knoll LJ, Gordon JI, 1994: Genetic and biochemical studies of protein N-myristoylation[J]. Annu Rev Biochem, 63, 869-914. doi: 10.1146/annurev.bi.63.070194.004253
-
Krausslich HG, Holscher C, Reuer Q, Harber J, Wimmer E, 1990: Myristoylation of the poliovirus polyprotein is required for proteolytic processing of the capsid and for viral infectivity[J]. J Virol, 64, 2433-2436. doi: 10.1128/JVI.64.5.2433-2436.1990
-
Lee YM, Chow M, 1992: Myristate modification does not function as a membrane association signal during poliovirus capsid assembly[J]. Virology, 187, 814-820. doi: 10.1016/0042-6822(92)90485-8
-
Li X, Fan P, Jin J, Su W, An D, Xu L, Sun S, Zhang Y, Meng X, Gao F, Kong W, Jiang C, 2013: Establishment of cell lines with increased susceptibility to EV71/CA16 by stable overexpression of SCARB2[J]. Virol J, 10, 250-. doi: 10.1186/1743-422X-10-250
-
Lin YW, Lin HY, Tsou YL, Chitra E, Hsiao KN, Shao HY, Liu CC, Sia C, Chong P, Chow YH, 2012: Human SCARB2-mediated entry and endocytosis of EV71[J]. PLoS ONE, 7, e30507-. doi: 10.1371/journal.pone.0030507
-
Lum LC, Wong KT, Lam SK, Chua KB, Goh AY, 1998: Neurogenic pulmonary oedema and enterovirus 71 encephalomyelitis[J]. Lancet, 352, 1391-.
-
Marc D, Drugeon G, Haenni AL, Girard M, van der Werf S, 1989: Role of myristoylation of poliovirus capsid protein VP4 as determined by site-directed mutagenesis of its N-terminal sequence[J]. EMBO J, 8, 2661-2668. doi: 10.1002/j.1460-2075.1989.tb08406.x
-
Marc D, Masson G, Girard M, van der Werf S, 1990: Lack of myristoylation of poliovirus capsid polypeptide VP0 prevents the formation of virions or results in the assembly of noninfectious virus particles[J]. J Virol, 64, 4099-4107. doi: 10.1128/JVI.64.9.4099-4107.1990
-
Mariani R, Skowronski J, 1993: CD4 down-regulation by nef alleles isolated from human immunodeficiency virus type 1-infected individuals[J]. Proc Natl Acad Sci USA, 90, 5549-5553. doi: 10.1073/pnas.90.12.5549
-
Martin-Belmonte F, Lopez-Guerrero JA, Carrasco L, Alonso MA, 2000: The amino-terminal nine amino acid sequence of poliovirus capsid VP4 protein is sufficient to confer N-myristoylation and targeting to detergent-insoluble membranes[J]. Biochemistry, 39, 1083-1090. doi: 10.1021/bi992132e
-
Martinez A, Traverso JA, Valot B, Ferro M, Espagne C, Ephritikhine G, Zivy M, Giglione C, Meinnel Tl, 2008: Extent of N-terminal modifications in cytosolic proteins from eukaryotes[J]. Proteomics, 8, 2809-2831. doi: 10.1002/pmic.200701191
-
Maurer-Stroh S, Eisenhaber B, Eisenhaber F, 2002: N-terminal N-myristoylation of proteins: prediction of substrate proteins from amino acid sequence[J]. J Mol Biol, 317, 541-557. doi: 10.1006/jmbi.2002.5426
-
Moscufo N, Simons J, Chow M, 1991: Myristoylation is important at multiple stages in poliovirus assembly[J]. J Virol, 65, 2372-2380. doi: 10.1128/JVI.65.5.2372-2380.1991
-
Mousnier A, Bell AS, Swieboda DP, Morales-Sanfrutos J, Perez-Dorado I, Brannigan JA, Newman J, Ritzefeld M, Hutton JA, Guedan A, Asfor AS, Robinson SW, Hopkins-Navratilova I, Wilkinson AJ, Johnston SL, Leatherbarrow RJ, Tuthill TJ, Solari R, Tate EW, 2018: Fragment-derived inhibitors of human N-myristoyltransferase block capsid assembly and replication of the common cold virus[J]. Nat Chem, 10, 599-606. doi: 10.1038/s41557-018-0039-2
-
Olokoltsov AA, Deniger D, Fleming EH, Roberts NJ Jr, Karpilow JM, Davey RA, 2007: Small interfering RNA profiling reveals key role of clathrin-mediated endocytosis and early endosome formation for infection by respiratory syncytial virus[J]. J Virol, 81, 7786-7800. doi: 10.1128/JVI.02780-06
-
Paul AV, Schultz A, Pincus SE, Oroszlan S, Wimmer E, 1987: Capsid protein VP4 of poliovirus is N-myristoylated[J]. Proc Natl Acad Sci USA, 84, 7827-7831. doi: 10.1073/pnas.84.22.7827
-
Paul AV, Rieder E, Kim DW, van Boom JH, Wimmer E, 2000: Identification of an RNA hairpin in poliovirus RNA that serves as the primary template in the in vitro uridylylation of VPg[J]. J Virol, 74, 10359-10370. doi: 10.1128/JVI.74.22.10359-10370.2000
-
Peng B, Robert-Guroff M, 2001: Deletion of N-terminal myristoylation site of HIV Nef abrogates both MHC-1 and CD4 down-regulation[J]. Immunol Lett, 78, 195-200. doi: 10.1016/S0165-2478(01)00250-4
-
Raju RV, Magnuson BA, Sharma RK, 1995: Mammalian myristoyl CoA: protein N-myristoyltransferase[J]. Mol Cell Biochem 149-, 150, 191-202.
-
Rein A, McClure MR, Rice NR, Luftig RB, Schultz AM, 1986: Myristylation site in Pr65gag is essential for virus particle formation by Moloney murine leukemia virus[J]. Proc Natl Acad Sci USA, 83, 7246-7250. doi: 10.1073/pnas.83.19.7246
-
Resh MD, 1999: Fatty acylation of proteins: new insights into membrane targeting of myristoylated and palmitoylated proteins[J]. Biochim Biophys Acta, 1451, 1-16. doi: 10.1016/S0167-4889(99)00075-0
-
Rhee SS, Hunter E, 1987: Myristylation is required for intracellular transport but not for assembly of D-type retrovirus capsids[J]. J Virol, 61, 1045-1053. doi: 10.1128/JVI.61.4.1045-1053.1987
-
Strauss M, Levy HC, Bostina M, Filman DJ, Hogle JM, 2013: RNA transfer from poliovirus 135S particles across membranes is mediated by long umbilical connectors[J]. J Virol, 87, 3903-3914. doi: 10.1128/JVI.03209-12
-
Strecker T, Maisa A, Daffis S, Eichler R, Lenz O, Garten W, 2006: The role of myristoylation in the membrane association of the Lassa virus matrix protein Z[J]. Virol J, 3, 93-. doi: 10.1186/1743-422X-3-93
-
Tan YW, Hong WJ, Chu JJ, 2016: Inhibition of enterovirus VP4 myristoylation is a potential antiviral strategy for hand, foot and mouth disease[J]. Antiviral Res, 133, 191-195. doi: 10.1016/j.antiviral.2016.08.009
-
Thinon E, Serwa RA, Broncel M, Brannigan JA, Brassat U, Wright MH, Heal WP, Wilkinson AJ, Mann DJ, Tate EW, 2014: Global profiling of co- and post-translationally N-myristoylated proteomes in human cells[J]. Nat Commun, 5, 4919-. doi: 10.1038/ncomms5919
-
Udenwobele DI, Su RC, Good SV, Ball TB, Varma Shrivastav S, Shrivastav A, 2017: Myristoylation: an important protein modification in the immune response[J]. Front Immunol, 8, 751-. doi: 10.3389/fimmu.2017.00751
-
Wagner E, Plank C, Zatloukal K, Cotten M, Birnstiel ML, 1992: Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: toward a synthetic virus-like gene-transfer vehicle[J]. Proc Natl Acad Sci USA, 89, 7934-7938. doi: 10.1073/pnas.89.17.7934
-
Weaver TA, Panganiban AT, 1990: N myristoylation of the spleen necrosis virus matrix protein is required for correct association of the Gag polyprotein with intracellular membranes and for particle formation[J]. J Virol, 64, 3995-4001. doi: 10.1128/JVI.64.8.3995-4001.1990
-
Wilcox C, Hu JS, Olson EN, 1987: Acylation of proteins with myristic acid occurs cotranslationally[J]. Science, 238, 1275-1278. doi: 10.1126/science.3685978
-
Wills JW, Craven RC, Achacoso JA, 1989: Creation and expression of myristylated forms of Rous sarcoma virus gag protein in mammalian cells[J]. J Virol, 63, 4331-4343. doi: 10.1128/JVI.63.10.4331-4343.1989
-
Wright MH, Heal WP, Mann DJ, Tate EW, 2010: Protein myristoylation in health and disease[J]. J Chem Biol, 3, 19-35. doi: 10.1007/s12154-009-0032-8
-
Xu L, Su W, Jin J, Chen J, Li X, Zhang X, Sun M, Sun S, Fan P, An D, Zhang H, Zhang X, Kong W, Ma T, Jiang C, 2014: Identification of luteolin as enterovirus 71 and coxsackievirus A16 inhibitors through reporter viruses and cell viability-based screening[J]. Viruses, 6, 2778-2795. doi: 10.3390/v6072778
-
Zauner W, Blaas D, Kuechler E, Wagner E, 1995: Rhinovirus-mediated endosomal release of transfection complexes[J]. J Virol, 69, 1085-1092. doi: 10.1128/JVI.69.2.1085-1092.1995
-
Zhang J, Dong M, Jiang B, Dai X, Meng J, 2012: Antigenic characteristics of the complete and truncated capsid protein VP1 of enterovirus 71[J]. Virus Res, 167, 337-342. doi: 10.1016/j.virusres.2012.05.019
-
Zhang YX, Huang YM, Li QJ, Li XY, Zhou YD, Guo F, Zhou JM, Cen S, 2017: A highly conserved amino acid in VP1 regulates maturation of enterovirus 71[J]. PLoS Pathog, 13, e1006625-. doi: 10.1371/journal.ppat.1006625
-
Zhu Y, Luo S, Sabo Y, Wang C, Tong L, Goff SP, 2017: Heme oxygenase 2 binds myristate to regulate retrovirus assembly and TLR4 signaling[J]. Cell Host Microbe, 21, 220-230. doi: 10.1016/j.chom.2017.01.002